Apolipoprotein E distribution among different plaque types in Alzheimer's disease: Implications for its role in plaque progression

Neuropathology and Applied Neurobiology

Volumn 22, Issue 4, 1996, Pages 334-341

  Sheng, J G ^a,c,d   Mrak, R E ^a,b,c   Griffin, W S T ^a,c,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cytokines; amyloid plaques

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MICROGLIA; NEURITE; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL LOBE;

EID: 0029757510     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb01112.x     Document Type: Article

References (37)

1. Chartier-Harlin M-C, Parfitt M. Legrain S et al. Apolipoprotein E, E4 allele as a major risk factor for sporadic early and late onset forms of Alzheimer's diseuse: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994: 3: 569-74
2. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993: 261: 921-3
3. Crutcher KA, Clay MA, Scott SA et al. Neurite degeneration elicited by apolipoprotein E peptides. Exp Neurol 1994: 130: 120-6
4. 1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron 1995; 14: 447-56
5. Diedrich JF, Minnigan H. Carp RI et al. Neuropathological changes in scrapie and Alzheimer's disease are assoeiated with inereased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 1991; 65: 4759-68
6. Gearing M, Schneider JA, Robbins RS et al. Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 1995; 54: 833-41
7. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB, Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988; 8: 2485-90
8. Griffin WST, Stanley LC, Yeralan O, Rovnaghi CR. Marshak DR, Methods for the study of cytokines in human neurodegenerative disease. Met Neurosci 1993; 17: 268-87
9. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995; 54: 276-81
10. Griffin WST, Stanley LC, Ling C et al. Brain interleukin-1 and S100 immunoreactivity elevated in Down's syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989; 86: 7611-15
11. Ikeda SI, Allsop D, Glenner GG. Morphology and distribution of plaque and related deposits in the brain of Alzheimer's disease and control cases. Lab Invest 1989; 60: 113-22
12. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in cerebellum in Alzheimer's disease. Am J Pathol 1989; 435: 309-19
13. Kernper T. Neuroanatomical and neuropathological changes in normal aging and in dementia. In: Clinical Neurobiology of Aging, Ed ML Albert, New York: Oxford University Press, 1984: 9-52
14. LaDu MJ, Falduto MT, Manelli AM et al. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994; 269: 23403-6
15. LaDu MJ, Pederson TM, Frail DE et al. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 1995; 270: 9039-42
16. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. Amyloid-associated proteins Alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994; 372: 45-46
17. Marshak DR, Pesce SA, Stanley LC, Griffin WST. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 1991; 13: 1-7
18. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
19. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995; 26: 816-23
20. Mrak RE, Sheng JG, Griffin WST, Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55: 273-9
21. Mufson EJ, Benzing WC, Cole GM et al Apolipoprotein E-immunoreactivity in aged Rhesus monkey cortex: Colocalization with amyloid plaques. Neurobiol Aging 1994; 15: 621-627
22. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991; 541: 163-66
23. Nathan BP, Bellosta S, Sanan DA et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850-52
24. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize Apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917: 148-61
25. Poirier J, Davignon J, Bouthillier D et al. Apolipoprolein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-99
26. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991; 11: 97-106
27. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques, and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991 12: 295-312
28. Roberts GW, Lofthouse R, Allsop D et al. CNS amyloid proteins in neurodegenerative diseases. Neurology 1988; 38: 1534-40)
29. Saunders AM, Schmader K, Breitner JCS et al Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993: 342: 710-11
30. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72
31. Schmechel DE, Saunders AM, Strittmatter WJ et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 9649-53
32. Sheng JG, Mrak RE, Griffin WST. S100β protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res J 1994; 39: 398-404
33. Strittmatter WJ, Roses AD. Apolipoprotein E: emerging story in the pathogenesis of Alzheimer's disease. The Neuroscientist 1995; 1: 298-306
34. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-81
35. Strittmatter WJ, Weisgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specilic effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993 90: 8098-102
36. Uchihara T, Duyckaerts C, He Y et al. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain, Neurosci Letts 1995 195: 5-8
37. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992; 135: 235-38